Solas Capital Management, LLC Processa Pharmaceuticals, Inc. Transaction History

Solas Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.68 - $3.55 $38,377 - $81,096	-22,844 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.01 - $5.21 $521,651 - $902,924	-173,306 Reduced 88.35%	22,844 $69,000
Q2 2021 Aug 16, 2021	SELL	$6.15 - $10.95 $23,677 - $42,157	-3,850 Reduced 1.93%	196,150 $1.61 Million
Q1 2021 May 17, 2021	SELL	$5.96 - $13.15 $1.49 Million - $3.29 Million	-250,000 Reduced 55.56%	200,000 $2.18 Million
Q4 2020 Feb 16, 2021	BUY	$3.95 - $8.48 $1.78 Million - $3.82 Million	450,000 New	450,000 $2.97 Million

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $14.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Solas Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Solas Capital Management, LLC with notifications on news.